Cardinal Health (CAH) Stock Buyback History
TTM buyback yield 3.57% · Shareholder yield (TTM) 3.57%.
TTM buyback yield
3.57%
Shareholder yield (TTM)
3.57%
5Y share count change
-17.4%
TTM buyback spend
$1.77B
SBC coverage (TTM)
3.84x
YoY change in spend
+2.0%
5Y CAGR of spend
+16.9%
Peak year (2007)
$3.66B
Cumulative spend
$21.17B
TTM metrics calculated from the four most recent reported quarters, ending (reported ).
Key takeaways
- Cardinal Health (CAH) repurchased about $1.77B of stock over the trailing twelve months.
- Diluted share count is down 17.4% over the last ~5 fiscal years — buybacks are net-shrinking the share base.
- TTM buyback ÷ stock-based-comp ratio of 3.84× — repurchases more than cover SBC dilution.
- Cash buyback spend has compounded at +16.9% per year over the latest 5-year window.
- TTM repurchases used about 45% of free cash flow remaining after dividends.
Buyback context per fiscal year
Annual repurchases alongside stock-based compensation, diluted share count and the year-over-year change — useful for SBC-coverage and dilution-offset reading at a glance.
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2025 | $765.00M | $244.00M | $521.00M | 0.24B | -2.0% | 1.91% |
| 2024 | $750.00M | $121.00M | $629.00M | 0.25B | -5.7% | 3.14% |
| 2023 | $2.00B | $96.00M | $1.90B | 0.26B | -6.1% | 8.33% |
| 2022 | $1.00B | $0.00 | $1.00B | 0.28B | -5.1% | 7.01% |
| 2021 | $200.00M | $89.00M | $111.00M | 0.29B | 0.3% | 1.21% |
| 2020 | $350.00M | $90.00M | $260.00M | 0.29B | -2.7% | 2.30% |
| 2019 | $600.00M | $82.00M | $518.00M | 0.30B | -4.4% | 4.23% |
| 2018 | $550.00M | $85.00M | $465.00M | 0.32B | -1.6% | 3.64% |
| 2017 | $600.00M | $96.00M | $504.00M | 0.32B | -3.0% | 2.44% |
| 2016 | $651.00M | $111.00M | $540.00M | 0.33B | -1.5% | 2.58% |
| 2015 | $1.04B | $110.00M | $926.00M | 0.34B | -2.9% | 3.75% |
| 2014 | $673.00M | $96.00M | $577.00M | 0.34B | 0.3% | 2.90% |
| 2013 | $450.00M | $93.00M | $357.00M | 0.34B | -1.4% | 2.78% |
| 2012 | $450.00M | $85.00M | $365.00M | 0.35B | -1.0% | 3.11% |
| 2011 | $270.00M | $79.50M | $190.50M | 0.35B | -2.5% | 1.72% |
| 2010 | $230.00M | $99.50M | $130.50M | 0.36B | -0.0% | 1.96% |
| 2009 | $0.00 | $122.80M | −$122.80M | 0.36B | -0.7% | — |
| 2008 | $1.18B | $122.30M | $1.06B | 0.36B | -10.1% | 8.97% |
| 2007 | $3.66B | $138.10M | $3.52B | 0.40B | -5.6% | 19.89% |
| 2006 | $1.50B | $237.30M | $1.26B | 0.43B | -1.7% | 8.03% |
| 2005 | $500.30M | $0.00 | $500.30M | 0.44B | 1.4% | 2.84% |
| 2004 | $1.50B | $0.00 | $1.50B | 0.43B | -5.3% | 6.91% |
| 2003 | $1.19B | $0.00 | $1.19B | 0.45B | 0.1% | 5.86% |
| 2002 | $308.30M | $0.00 | $308.30M | 0.45B | -2.2% | 1.73% |
| 2001 | $139.40M | $0.00 | $139.40M | 0.46B | 2.0% | 0.63% |
| 2000 | $341.40M | $0.00 | $341.40M | 0.45B | 6.2% | — |
| 1999 | $47.80M | $0.00 | $47.80M | 0.43B | 2.6% | — |
| 1998 | $155.00M | $0.00 | $155.00M | 0.42B | 74.9% | — |
| 1997 | $37.70M | $0.00 | $37.70M | 0.24B | 3.4% | — |
| 1996 | $1.80M | $0.00 | $1.80M | 0.23B | — | — |
| 1995 | $6.30M | $0.00 | $6.30M | — | — | — |
| 1994 | $20.70M | $0.00 | $20.70M | — | — | — |
| 1993 | $700.00K | $0.00 | $700.00K | — | — | — |
| 1992 | $200.00K | $0.00 | $200.00K | — | — | — |
| 1991 | $0.00 | $0.00 | $0.00 | — | — | — |
| 1990 | $1.00M | $0.00 | $1.00M | — | — | — |
Cash buyback spend (USD) — annual & quarterly history
Trailing-twelve-month and per-period cash repurchases for Cardinal Health (CAH) from the consolidated cash flow statement (line: common stock repurchased), in USD as filed.
Cash buyback spend over time for Cardinal Health (CAH)
Per-period cash repurchases
Cash buyback spend annual + quarterly history for Cardinal Health (CAH)
| Fiscal year | Period ended | Reported | Buyback Spend | YoY | YoY change |
|---|---|---|---|---|---|
| 2025 | $765.00M | +2.0% | +$15.00M | ||
| 2024 | $750.00M | -62.5% | -$1.25B | ||
| 2023 | $2.00B | +100.0% | +$1.00B | ||
| 2022 | $1.00B | +400.0% | +$800.00M | ||
| 2021 | $200.00M | -42.9% | -$150.00M | ||
| 2020 | $350.00M | -41.7% | -$250.00M | ||
| 2019 | $600.00M | +9.1% | +$50.00M | ||
| 2018 | $550.00M | -8.3% | -$50.00M | ||
| 2017 | $600.00M | -7.8% | -$51.00M | ||
| 2016 | $651.00M | -37.2% | -$385.00M | ||
| 2015 | $1.04B | +53.9% | +$363.00M | ||
| 2014 | $673.00M | +49.6% | +$223.00M | ||
| 2013 | $450.00M | 0.0% | $0 | ||
| 2012 | $450.00M | +66.7% | +$180.00M | ||
| 2011 | $270.00M | +17.4% | +$40.00M | ||
| 2010 | $230.00M | — | +$230.00M | ||
| 2009 | $0 | -100.0% | -$1.18B | ||
| 2008 | $1.18B | -67.7% | -$2.48B | ||
| 2007 | $3.66B | +144.1% | +$2.16B | ||
| 2006 | $1.50B | +199.8% | +$999.60M | ||
| 2005 | $500.30M | -66.6% | -$999.70M | ||
| 2004 | $1.50B | +25.9% | +$308.30M | ||
| 2003 | $1.19B | +286.5% | +$883.40M | ||
| 2002 | $308.30M | +121.2% | +$168.90M | ||
| 2001 | $139.40M | -59.2% | -$202.00M | ||
| 2000 | $341.40M | +614.2% | +$293.60M | ||
| 1999 | $47.80M | -69.2% | -$107.20M | ||
| 1998 | $155.00M | +311.1% | +$117.30M | ||
| 1997 | $37.70M | +1994.4% | +$35.90M | ||
| 1996 | $1.80M | -71.4% | -$4.50M | ||
| 1995 | $6.30M | -69.6% | -$14.40M | ||
| 1994 | $20.70M | +2857.1% | +$20.00M | ||
| 1993 | $700,000 | +250.0% | +$500,000 | ||
| 1992 | $200,000 | — | +$200,000 | ||
| 1991 | $0 | -100.0% | -$1.00M | ||
| 1990 | $1.00M | — | — |
Cardinal Health (CAH) most recent annual buyback spend stands at $765.00M (2025) – edged up 2.0% year-over-year.
Through 2020–2025 (5 years), Cardinal Health buyback spend delivered a +16.9% annualised rate; with the latest reading among the more recent periods of the dataset.
Cardinal Health buyback spend plunged from $3.66B in 2007 to $765.00M in 2025, a 79.1% drawdown.
Across the available history, buyback spend reached its high of $3.66B in 2007 and its low of $0 in 1991.
Within Healthcare, Cardinal Health (CAH) ranks 7th among 8 peers we track. The peer median for buyback spend is $2.75B.
Cardinal Health Buyback Spend 2025: $765.00M
Cardinal Health buyback spend in 2025 was $765.00M, edged up 2.0% from 2024.
Cardinal Health Buyback Spend 2024: $750.00M
Cardinal Health buyback spend in 2024 was $750.00M, plunged 62.5% below 2023.
Cardinal Health Buyback Spend 2023: $2.00B
Cardinal Health buyback spend in 2023 was $2.00B, surged 100.0% from 2022.
Cardinal Health Buyback Spend 2022: $1.00B
Cardinal Health buyback spend in 2022 was $1.00B, surged 400.0% from 2021.
Cardinal Health Buyback Spend 2021: $200.00M
Cardinal Health buyback spend in 2021 was $200.00M.
See more financial history for Cardinal Health (CAH).
Sector peers by buyback spend
Companies in the same sector as Cardinal Health, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group (UNH) | $5.54B | Healthcare |
| Merck & Co. (MRK) | $5.08B | Healthcare |
| Eli Lilly (LLY) | $4.11B | Healthcare |
| Novo Nordisk (NVO) | $1.39B | Healthcare |
| AbbVie (ABBV) | $980.00M | Healthcare |
| AstraZeneca (AZN) | $719.66M | Healthcare |
| Amgen (AMGN) | $0 | Healthcare |
Share count history
Diluted weighted-average shares drive the EPS denominator and per-share capital-return maths. A falling diluted share count means buybacks are outpacing dilution from stock-based compensation and option exercises.
Diluted vs basic shares (annual)
Year-over-year change in diluted shares
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield over time
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Buybacks vs stock-based compensation
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 3.84×.
Capital allocation mix
How Cardinal Health splits cash returned to shareholders between dividends and buybacks, plus the headroom on free cash flow that's still available for additional repurchases.
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $3.90B (TTM FCF − TTM dividends, clamped at zero).
Data & methodology
Where do buyback, dividend and compensation figures come from?
Cash buyback spend (common stock repurchased), dividends paid and stock-based compensation come from Cardinal Health's consolidated cash flow statements — quarterly 10-Q and annual 10-K SEC filings, in USD as reported.
How are diluted shares and yields calculated?
Diluted weighted-average share counts come from the income statement (EPS denominator). Trailing twelve-month (TTM) aggregates sum the four most recent reported quarters. Buyback and dividend yields divide TTM cash flows by market capitalisation at the latest quarter-end.
How is buyback capacity defined?
Capacity compares TTM repurchases to free cash flow after dividends: operating cash flow minus capital expenditure, minus dividends paid, versus actual buybacks over the same trailing window.
Is this investment advice?
No. Figures are for informational and educational use only. Past buybacks and dividends do not predict future returns.
Frequently asked questions
Does Cardinal Health buy back its own stock?
Yes, Cardinal Health (CAH) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
How much does Cardinal Health spend on share buybacks?
Trailing twelve months (TTM) buyback spend is about $1.77B (sum of the last four quarterly cash-flow periods in our data). Figures are illustrative; verify in filings.
What is Cardinal Health's buyback yield?
TTM buyback yield is about 3.57% (TTM buyback spend divided by market cap at the latest quarter-end in our data).
What is Cardinal Health's shareholder yield?
Shareholder yield combines dividend yield and buyback yield. For the latest period we show approximately 3.57% combined (TTM-based where available).
Is Cardinal Health diluting shareholders?
Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has Cardinal Health's share count changed?
Diluted weighted average shares changed by about -17.4% over roughly five fiscal years (annual income statement data).
What is Cardinal Health's buyback spend?
Latest reported buyback spend for Cardinal Health (CAH) is $1.77B (period ending March 31, 2026).
How has Cardinal Health buyback spend changed year-over-year?
Cardinal Health (CAH) buyback spend changed +2.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Cardinal Health buyback spend?
Cardinal Health (CAH) buyback spend compound annual growth rate is +16.9% over the most recent 5 years available.
When did Cardinal Health buyback spend hit its highest annual value?
Cardinal Health buyback spend reached its highest annual value of $3.66B in 2007.
What was Cardinal Health buyback spend in 2024?
Cardinal Health (CAH) buyback spend in 2024 was $750.00M.
What was Cardinal Health buyback spend in 2025?
Cardinal Health (CAH) buyback spend in 2025 was $765.00M.
Explore more
CAH Overview
Company profile, financial tools, and key metrics
CAH Revenue Counter
Earns $7,945 every second. See per minute, hour, and day.
CAH Earnings Counter
Earns $49.44 per second net profit. See per minute, hour, and day.
CAH Economic Scale
Exceeds Hungary's GDP. Compare with world economies.
CAH What If Invested
What if you had invested $1,000? See historical returns from any date.
CAH How It Makes Money
Discover visual breakdown of $250.55B in revenue — where it comes from and where it goes.
CAH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
CAH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
CAH Daily Price Character
Balanced · 48.0% historical win rate (green days). Streaks & record days.
CAH Stock Split History
11 splits on record. Dates, ratios, and cumulative multiple.
CAH Dividend Profile
Yield: 1.03%. Safety: 5/8. See full history.
CAH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
CAH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.
CAH Dividend Capture
Historical pre-ex touch stats, gap distribution, after-tax calculator, and a backtest simulator (limit-order vs MOC exit).
CAH Financials
Revenue, EPS, EBITDA, market cap, debt and balance sheet history with annual and quarterly data.